New research by investigators in Ghent, Belgium shows that intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be an effective strategy in fighting antimicrobial resistance. The findings are presented at ASM Microbe 2023, the annual meeting of the American Society for Microbiology.
AI startup Leucine raises $7m for drug manufacturing digital twin platform – Pharmaceutical Technology
The software uses large language models (LLMs) to rapidly transforms paper-based information into digital data. Image credit: Shutterstock/arleksey. Leucine is joining the artificial intelligence (AI)
October 17, 2023